. 2019 Dec 10;34(1):51–65. doi: 10.1016/j.idc.2019.10.006

Table 2.

Examples of reporting rules to influence antibiotic decisions

Rule	Rationale
Daptomycin tested but not reported for staphylococci and enterococci Linezolid reported for respiratory cultures of Staphylococcus aureus but not blood cultures Ceftaroline tested but not reported Cascaded reporting of linezolid for enterococci (only reported if vancomycin resistant) Cascaded reporting of cefepime and ceftazidime for Enterobacteriaceae (only reported if ceftriaxone resistant) Cascaded reporting of aminoglycosides for gram-negative rods	Promote antibiotic stewardship
Trimethoprim/sulfamethoxazole reported for wound cultures of S aureus but not blood cultures Fluoroquinolones and rifampin tested but not reported for staphylococci Tetracycline reported for wound and urine cultures but not blood cultures Perform D-test for staphylococci and streptococci that are erythromycin resistant and clindamycin susceptible β-Lactams not reported for oxacillin-resistant staphylococci	Prevent inappropriate treatment

Rule

Rationale

Daptomycin tested but not reported for staphylococci and enterococci
Linezolid reported for respiratory cultures of Staphylococcus aureus but not blood cultures
Ceftaroline tested but not reported
Cascaded reporting of linezolid for enterococci (only reported if vancomycin resistant)
Cascaded reporting of cefepime and ceftazidime for Enterobacteriaceae (only reported if ceftriaxone resistant)
Cascaded reporting of aminoglycosides for gram-negative rods

Promote antibiotic stewardship

Trimethoprim/sulfamethoxazole reported for wound cultures of S aureus but not blood cultures
Fluoroquinolones and rifampin tested but not reported for staphylococci
Tetracycline reported for wound and urine cultures but not blood cultures
Perform D-test for staphylococci and streptococci that are erythromycin resistant and clindamycin susceptible
β-Lactams not reported for oxacillin-resistant staphylococci

Prevent inappropriate treatment